Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Winrevair® 60 mg powder and solvent for solution for injection (1 vial - pack) {equilateral_black_triangle}

Active Ingredient:
ATC code: 
C02KX06
{info_black}
About Medicine
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 02 Jun 2025

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

Below is a text only representation of the Patient Information Leaflet (ePIL).

The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on {phone} 0800 198 5000. The product code(s) for this leaflet is: PLGB 53095/0105.

Winrevair 45 mg & 60 mg powder and solvent for solution for injection

Package leaflet: Information for the patient

Winrevair® 45 mg powder and solvent for solution for injection

Winrevair® 60 mg powder and solvent for solution for injection

sotatercept

▼This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects.

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor, pharmacist or nurse.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

What is in this leaflet

1. What Winrevair is and what it is used for
2. What you need to know before you use Winrevair
3. How to use Winrevair
4. Possible side effects
5. How to store Winrevair
6. Contents of the pack and other information

1. What Winrevair is and what it is used for

Winrevair contains the active substance sotatercept.

It is used with other therapies to treat pulmonary arterial hypertension (PAH) in adults. PAH is a type of high blood pressure in the arteries of your lungs. In PAH, these arteries get narrower, which makes it harder for the heart to pump blood through these vessels, and leads to symptoms like fatigue, dizziness, and difficulty breathing.

Winrevair acts on the causes of PAH responsible for the narrowing of the arteries of your lungs. This makes it easier for the heart to pump blood to your lungs and improves your ability to be physically active.

2. What you need to know before you use Winrevair
Do not use Winrevair
  • if you are allergic to sotatercept or any of the other ingredients of this medicine (listed in section 6).
  • If the number of platelets in your blood is repeatedly very low.

Warnings and precautions

Winrevair can increase the levels of haemoglobin in your blood, decrease the number of platelets in your blood, or increase the risk of serious bleeding.

Talk to your doctor or pharmacist before and while using Winrevair if you have:

  • high levels of haemoglobin in your blood (a protein in red blood cells that carries oxygen).

This can increase the chance of a blood clot forming that can block a blood vessel. Your doctor will check haemoglobin levels with regular blood tests before each of your first 5 doses of Winrevair, or longer before each dose if needed, and regularly while you are using this medicine.

  • low number of platelets in your blood (blood cells that help blood to clot).
    This can cause easy bruising, continued bleeding from cuts and nosebleeds. Your doctor will check your number of platelets with regular blood tests before each of your first 5 doses of Winrevair, or longer before each dose if needed, and regularly while you are using this medicine. In case the number of platelets in your blood is repeatedly very low, your doctor will not start your treatment.
  • signs and symptoms of serious bleeding:
    • persistent headache
    • nausea
    • weakness
    • black or tarry stool
    • blood in your stool
    • bright red blood from vomiting or coughing
    • persistent abdominal cramps
    • severe back pain
    • abnormally heavy menstrual bleeding

These are signs and symptoms of serious bleeding that can happen if you take Winrevair and are more likely to happen if you take Winrevair with certain medicines. Your doctor will inform you on how to recognize them. Talk to your doctor if you notice any of these signs or symptoms. Serious bleeding could lead to hospitalisation, need for blood transfusion or other treatments, and could be life-threatening.

Children and adolescents

Do not give this medicine to children and adolescents below the age of 18 years. It is not known if this medicine is safe and works in people under 18 years of age.

Other medicines and Winrevair

Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.

Pregnancy, breast-feeding and fertility

If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.

Pregnancy:

Winrevair may harm your unborn baby.

This medicine is not recommended during pregnancy. Your doctor should do a pregnancy test before you start your treatment and you should use effective birth control (contraception) during your treatment and for at least 4 months after the last dose of Winrevair. Ask your doctor or pharmacist about birth control methods that would work well for you.

Tell your doctor immediately if you become pregnant or think you may be pregnant while using this medicine.

Breast-feeding:

It is not known whether Winrevair passes into breast milk. Do not breastfeed during your treatment and for at least 4 months after the last dose of Winrevair. Talk to your doctor or pharmacist about the best way to feed your baby.

Fertility:

Winrevair may decrease female and male fertility.

Driving and using machines

It is unlikely that this medicine will affect your ability to drive and use machines.

Winrevair contains sodium

This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially ‘sodium free’.

Winrevair contains polysorbate 80

This medicine contains 0.20 mg of polysorbate 80 in each mL of reconstituted solution. Polysorbates may cause allergic reactions. Tell your doctor if you have any known allergies.

3. How to use Winrevair

Always use this medicine exactly as your doctor, pharmacist or nurse has told you. Check with your doctor, pharmacist or nurse if you are not sure.

The recommended dosing schedule is one injection every 3 weeks.

Your dose
  • Your dose of Winrevair depends on your body weight and blood tests. You will begin your treatment with a dose of 0.3 mg/kg, which will be increased to 0.7 mg/kg.
  • Your doctor will tell you how much Winrevair to take and when to take it. It is very important that you follow the instructions from your doctor.
  • Do not take Winrevair more often than your doctor tells you to. If you are not sure when to take Winrevair, talk to your doctor or pharmacist.

Your doctor will monitor your dose
  • Before each of your first 5 doses, or longer before each dose if needed, and regularly while taking Winrevair, your doctor will do blood tests. This is so your doctor can monitor you and find the best dose for you.
  • Your doctor may change your dose, delay treatment, or stop treatment depending on how you respond to Winrevair.

How you will use Winrevair

You will take Winrevair, as an injection just under your skin (subcutaneous (SC)) only in these injection sites:

  • stomach (abdomen), at least 5 cm away from the belly button, or
  • upper thigh

Note: In case your doctor or nurse is giving you the injection, they may also use your upper arm as injection site as they have received training in how to do it properly.

Before you use Winrevair
  • If your doctor decides that you or your caregiver can give the injections of Winrevair at home, you or your caregiver should receive training. This training will teach you the right way to prepare and inject Winrevair. Do not try to inject Winrevair until your doctor has shown you how to do it the right way.
  • Your doctor will tell you how much Winrevair to take and when to take it.
  • Read the separate “Instructions for Use” booklet that comes with Winrevair.

If you use less or more Winrevair than you should

If you use less or more Winrevair than you should, talk to your doctor or pharmacist.

If you forget to use Winrevair

If you miss your prescribed dose of Winrevair and it is within 3 days of when you should have taken it, take it immediately and follow your original schedule for your next dose. If you miss your prescribed dose of Winrevair and it is more than 3 days of when you should have taken it, your injection schedule has to be changed, talk to your doctor or pharmacist for guidance.

If you stop using Winrevair

Do not change your dose or stop taking Winrevair without talking to your doctor.

If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Serious side effects:

Talk to your doctor or pharmacist immediately if you notice:

  • Easy bruising, prolonged bleeding from cuts and nosebleeds. These could be signs of a low number of platelets (thrombocytopenia). This will be shown in your blood tests.

In addition, your doctor will do regular blood tests to notice whether you have:

  • High levels of haemoglobin.

The serious side effects above may affect more than 1 in 10 people.

Other possible side effects:

Talk to your doctor or pharmacist if you notice any of the following:

Very common (may affect more than 1 in 10 people):

  • Headache
  • Nosebleeds (epistaxis)
  • Spider veins or tiny blood vessels that look like pink or red lines on the skin (telangiectasia)
  • Diarrhoea
  • Dizziness
  • Skin rash

Common (may affect up to 1 in 10 people):

  • High blood pressure
  • Redness of the skin
  • Bleeding gums
  • Itching at the injection site

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Winrevair

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the vial and the carton after “EXP”. The expiry date refers to the last day of that month.

Store in a refrigerator (2 °C – 8 °C). Do not freeze. Store in the original package in order to protect from light.

You should inject this medicine right away after mixing the medicine powder with the sterile water for injection, but no later than 4 hours after mixing.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information
What Winrevair contains
  • The active substance is sotatercept. Each vial contains 45 mg or 60 mg of sotatercept. After reconstitution, each mL of solution contains 50 mg of sotatercept.
  • The other ingredients are
    • In the powder: citric acid monohydrate (E330), sodium citrate (E331) (see section 2 “Winrevair contains sodium”), polysorbate 80 (E433) (see section 2 “Winrevair contains polysorbate 80”) and sucrose.
    • In the solvent: water for injections.

What Winrevair looks like and contents of the pack

Winrevair is a powder and solvent for solution for injection (powder for injection). The white to off-white powder comes in a 2 mL glass vial containing 45 mg or 60 mg of sotatercept. The solvent is a clear and colourless water for injections in a prefilled syringe of 1 mL or 1.3 mL.

Winrevair 45 mg is available in:

  • Pack containing 1 vial 45 mg (powder), 1 prefilled syringe 1.0 mL (solvent), 1 vial adaptor, 1 dosing syringe, 1 needle and 4 alcohol wipes.
  • Pack containing 2 vials 45 mg (powder), 2 prefilled syringes 1.0 mL (solvent), 2 vial adaptors, 1 dosing syringe, 1 needle and 8 alcohol wipes.

Winrevair 60 mg is available in:

  • Pack containing 1 vial 60 mg (powder), 1 prefilled syringe 1.3 mL (solvent), 1 vial adaptor, 1 dosing syringe, 1 needle and 4 alcohol wipes.
  • Pack containing 2 vials 60 mg (powder), 2 prefilled syringes 1.3 mL (solvent), 2 vial adaptors, 1 dosing syringe, 1 needle and 8 alcohol wipes.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder:

Merck Sharp & Dohme (UK) Limited
120 Moorgate
London
EC2M 6UR
United Kingdom

Manufacturer:

Merck Sharp & Dohme B.V.
Waarderweg 39
2031 BN Haarlem
The Netherlands

For any information about this medicine, please contact:

Merck Sharp & Dohme (UK) Limited
Tel: +44 (0) 208 154 8000

This leaflet was last revised in September 2024.

© 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.

New MAA

Merck Sharp & Dohme (UK) Limited
Company image
Address
120 Moorgate, London, EC2M 6UR, UK
Telephone
+44 (0)208 154 8000 (all hours)
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)208 154 8001